Electrical Safety and EMC Evaluation with IEC 60601 in Canada

1. Key takeaways

The Canadian dossier for an active (electrically powered) medical device must include evaluation evidence for electrical safety, typically against the IEC 60601-1 series including the applicable collateral and particular standards, and for electromagnetic compatibility (EMC), typically against IEC 60601-1-2. Products with wireless functionality must additionally assess wireless coexistence. The IEC 60601 series is a set of consensus standards, not mandatory provisions of the Regulations; its role is to supply the recognised technical method by which the safety and effectiveness requirements of sections 10 to 20 of the Medical Devices Regulations are demonstrated. What the reviewer looks for is completeness — the right family of standards for the device type, both directions of EMC, and labelling performance specifications that agree with the evaluation reports.

• Electrical safety evidence typically follows the IEC 60601-1 series with applicable collateral and particular standards.
• EMC evidence typically follows IEC 60601-1-2 and must cover both emissions and immunity.
• Wireless functionality triggers a wireless coexistence assessment.
• Performance specifications required for correct use are a mandatory label item under section 21(1)(h).
• The IEC 60601 family is a consensus standard, not a Regulation provision.

2. Legal basis

The table below lists the sources used in this article. The Medical Devices Regulations provisions were verified against Justice Laws; the IEC documents are cited as consensus standards; and the Health Canada content on regulated active devices was verified against canada.ca.

3. Expert insights

Insight 1: IEC 60601-1 is a series, not a single standard.

Beyond the basic safety standard, the IEC 60601 family contains collateral standards that address horizontal topics applicable across device types, and particular standards written for specific device categories. Selecting only the basic standard is usually insufficient: the applicable particular standard number must be identified for the product type, and the relevant collateral standards — for example those covering specific hazards or environments — must be included where they apply. The correct starting point is therefore a mapping exercise: list the device type, find the particular standard that governs it, then walk the collateral standards and mark which ones the device falls under. A dossier that lists the full applicable set, and states for each standard why it applies or does not, gives the reviewer a complete picture and prevents the deficiency request that follows from a missing particular standard discovered mid-review.

Insight 2: EMC evaluation runs in two directions, emissions and immunity.

IEC 60601-1-2 examines both the electromagnetic disturbances the equipment emits into its surroundings and the equipment’s ability to withstand the electromagnetic environment it operates in. Both directions produce evidence that must appear in the dossier. A device that passes emission limits but has not been shown to tolerate the interference of its intended environment is only half evaluated, and the same is true in reverse. The two directions also connect to labelling in different ways: immunity performance may need to be described so users know the operating environment, and emission characteristics inform where the device can be used. Planning the EMC programme with both directions from the start avoids re-testing and keeps the evaluation report and the label consistent with each other.

Insight 3: performance specifications are a mandatory label item and cross-validate the electrical safety evaluation.

Under section 21(1)(h), unless immediately apparent to the intended user, the label must state the device’s medical conditions, purposes and uses, and the performance specifications necessary for correct use. For active devices, many of those specifications — power characteristics, accuracy under specified conditions, essential performance parameters — come directly out of the electrical safety and EMC evaluations. This creates a natural cross-check: the performance parameters confirmed in the evaluation reports should be findable as corresponding statements on the label, and label claims that appear nowhere in the evaluation evidence are exactly the kind of inconsistency a reviewer will flag. Maintaining the alignment between report and label is therefore not just good practice but a direct consequence of the labelling provision.

Insight 4: the classification of active devices is determined by the Schedule 1 rules.

In the official Health Canada examples, insulin pumps and X-ray machines are both regulated devices. Their specific class, however, is not inferred from the fact that they are active or from a general assumption that active means high risk; it is determined by working through the applicable rules in Part 1 of Schedule 1. The classification rationale in the dossier should show that walk-through: which rules were considered, which condition of each rule was met, and how the final class follows. Presuming a class because the device is electrically powered — rather than deriving it from the rules — produces classification rationales that collapse under review and can invalidate downstream decisions such as the evidence requirements that attach to the class.

4. Practical recommendations

• List for the product type the full set of applicable IEC 60601 series standards: basic, collateral and particular.
• Cover both directions of EMC — emissions and immunity — in the evaluation evidence.
• Supplement a wireless coexistence assessment for products with wireless functionality.
• Present the key performance parameters on the label under section 21(1)(h) and keep them consistent with the evaluation reports.
• When citing the IEC series, identify the standards as consensus standards.

5. Verification checklist

• □ The applicable IEC 60601 series list is complete (basic plus collateral plus particular).
• □ Electrical safety evaluation evidence is complete.
• □ EMC evaluation covers both emissions and immunity.
• □ The wireless coexistence assessment is complete for products with wireless functionality.
• □ The performance specifications on the label are consistent with the evaluation reports.
• □ Cited standards are identified as consensus standards.

Regulatory information verified as of October 28, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com